UNSPSC 85444606: The diagnosis of antiviral drugs

In this classification, this covers the group of activities that yields a diagnosis of antiviral drugs. Antiviral drugs is listed In The World Health Organization's International Statistical Classification of Diseases and Related Health Problems (ICD-10) as a four-character category under code Y41.5.

UNSPSC 85444606 The diagnosis of antiviral drugs (Commodity) shows a mismatch between the code's nominal scope and recent state and local procurement activity. The three most recent opportunities posted under this code are diagnostic imaging systems procurement, special education contracted services, and health professional temporary staffing — none of which align with antiviral drug diagnosis or pharmaceutical testing. The code does not reflect the diagnostic tools, clinical laboratory services, or pharmaceutical-related procurement that its title suggests state and local governments are actually seeking. The issuing bodies include a county health system (San Mateo Medical Center), an independent school district (Birdville ISD in Texas), and a county health authority (Santa Clara County Health System), but their recent buys under this code address clinical staffing, imaging infrastructure, and educational services rather than antiviral drug diagnostics or related pharmaceutical procurement.

The recent activity spans California and Texas, but the opportunities show no coherent procurement pattern related to antiviral drug diagnosis or pharmaceutical testing. San Mateo Medical Center posted an RFP for a diagnostic imaging PACS system due October 21, 2026, requiring enterprise-grade radiology and cardiology imaging with EPIC integration; Birdville ISD posted an RFQ for special education contracted services including speech therapy and occupational therapy due October 21, 2026; and Santa Clara County Health System posted an RFQ to establish a qualified vendor pool for temporary health professional staffing (audiology, cardiology, diagnostic imaging, orthopedic, and therapy services) due October 7, 2026. The code appears to be mistagged across these solicitations and does not support a reliable procurement signal for vendors focused on antiviral drug diagnostics or pharmaceutical services.